Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Impact of NSAID prescribing in pleurodesis surgery after pneumothorax
2024-511226-32-00Phase 4Authorised
- Sponsor
- CHU Amiens-Picardie
- Start
- Jul 2024
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial of ketoprofen in pneumothorax (2 arms), sponsored by CHU Amiens-Picardie. Primary endpoint: Duration of pleural drainage. Planned start Jul 2024; status: authorised.
02
Drugs
ketoprofen
03
Conditions
pneumothorax
Beyond the preview
Go deeper on 2024-511226-32-00.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2024-511226-32-00.